Trade Mark Journal No.2026/043 23 October 2026
WO0000001940987 (5)
Office of origin: United States of America
Date of International Registration:20 August 2026
Date of designation in the UK:
20 August 2026

International priority date claimed: 20 February 2026
(United States of America)
(99662030)
- Class 5
- Nasal sprays comprised of biocompatible plasmonic and magnetoelectric nanoparticles for medical use, namely, for use in brain-computer interface (BCI) systems that integrate with human brain tissue to enable non-invasive stimulation and recording of neural activity, and provide real-time diagnostics for enhanced neurological treatments.
Subsense, Inc.
Representative: Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP, 2050 Main Street,, Suite 1100, Irvine CA 92614, UNITED STATES OF AMERICA